Clinical activity of durvalumab for patients with advanced mismatch repair-deficient and repair-proficient endometrial cancer. A nonrandomized phase 2 clinical trial.

Yoland C AntillPeey-Sei KokKristy RobledoSonia YipMichelle CumminsDeborah SmithAmanda SpurdleElizabeth BarnesYeh Chen LeeMichael FriedlanderSally Baron-HayCatherine ShannonJermaine CowardPhilip BealeGeraldine GossTarek MeniawyJanine LombardJohn AndrewsMartin R StocklerLinda Mileshkinnull null

Published in: Journal for immunotherapy of cancer (2021)

ANZGOG1601, ACTRN12617000106336, and NCT03015129.

Keyphrases

endometrial cancer
clinical trial
study protocol
open label
double blind